The Board of Directors of Kaken Pharmaceutical Co., Ltd. has authorized a buyback plan on May 11, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,413 JPY | -0.15% | +0.74% | +1.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.73% | 841M | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- 4521 Stock
- News Kaken Pharmaceutical Co., Ltd.
- Kaken Pharmaceutical Co., Ltd. authorizes a Buyback Plan.